Among the parasitic diseases, Canine Visceral Leishmaniasis (CVL) is included in the systemic illnesses of chronic evolution that attack men and dogs, presenting varied clinical manifestations as cachexia, dermatologic lesions, peripheral ...
Brito Fábio Luiz da Cunha +5 more
doaj
Effective immuno-therapeutic treatment of Canine Leishmaniasis. [PDF]
Ramos RAN +4 more
europepmc +1 more source
First Report of Autochthonous Canine Leishmaniasis in Hong Kong. [PDF]
Sandy J +3 more
europepmc +1 more source
This paper describes an epidemiologic investigation carried out in Imbiribeira district, where a canine visceral leishmaniasis case was recorded. Despite the absence of seropositive dogs and sand flies, these findings are not sufficient to discard the ...
Filipe Dantas-Torres +3 more
doaj
Pre-test probability and likelihood ratios for clinical findings in canine leishmaniasis. [PDF]
Galán-Relaño Á +6 more
europepmc +1 more source
Gut Microbiota and Lymphocyte Subsets in Canine Leishmaniasis. [PDF]
Meazzi S +6 more
europepmc +1 more source
MicroRNA-21 and microRNA-148a affects PTEN, NO and ROS in canine leishmaniasis. [PDF]
De Freitas JH +8 more
europepmc +1 more source
Seroprevalence and Factors Associated with Canine Leishmaniasis in Baringo County, Kenya: Implications for an Integrated One Health Surveillance. [PDF]
Maingi HN +9 more
europepmc +1 more source
Forecasting future trends in canine leishmaniasis through dynamic modeling. [PDF]
Fonseca I Llopis X +2 more
europepmc +1 more source
A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis. [PDF]
Alonso A +8 more
europepmc +1 more source

